DIAGNOS Inc.
DGNOF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $30,916 | $18,011 | $28,906 | $21,868 |
| - Cash | $352 | $118 | $89 | $70 |
| + Debt | $2,388 | $2,497 | $3,072 | $3,286 |
| Enterprise Value | $32,951 | $20,390 | $31,889 | $25,084 |
| Revenue | $11 | $19 | $18 | $26 |
| % Growth | -43.9% | 5.5% | -29.4% | – |
| Gross Profit | -$259 | -$372 | -$290 | -$275 |
| % Margin | -2,377.6% | -1,919.5% | -1,578.4% | -1,054.6% |
| EBITDA | -$687 | -$956 | -$1,153 | -$1,029 |
| % Margin | -6,308.3% | -4,925.2% | -6,271.1% | -3,953.1% |
| Net Income | -$787 | -$1,113 | -$1,337 | -$1,213 |
| % Margin | -7,232.4% | -5,738% | -7,270.7% | -4,658.8% |
| EPS Diluted | -0.008 | -0.011 | -0.014 | -0.014 |
| % Growth | 29.4% | 19.3% | 6.2% | – |
| Operating Cash Flow | -$645 | -$904 | -$1,241 | -$1,092 |
| Capital Expenditures | -$4 | -$4 | -$2 | -$4 |
| Free Cash Flow | -$832 | -$907 | -$1,243 | -$1,096 |